Morgan Stanley’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10K | Sell |
1,627
-1
| -0.1% | -$6 | ﹤0.01% | 7047 |
|
|
2026
Q1 | $7.93K | Sell |
1,628
-41
| -2% | -$229 | ﹤0.01% | 7018 |
|
|
2025
Q4 | $11.2K | Sell |
1,669
-1
| -0.1% | -$6 | ﹤0.01% | 6864 |
|
|
2025
Q3 | $7.32K | Sell |
1,670
-1,286
| -44% | -$6.1K | ﹤0.01% | 6989 |
|
|
2025
Q2 | $13.1K | Sell |
2,956
-5,514
| -65% | -$23K | ﹤0.01% | 6780 |
|
|
2025
Q1 | $47.9K | Sell |
8,470
-19,350
| -70% | -$248K | ﹤0.01% | 6281 |
|
|
2024
Q4 | $587K | Buy |
27,820
+11,785
| +73% | +$271K | ﹤0.01% | 5356 |
|
|
2024
Q3 | $431K | Buy |
16,035
+9,435
| +143% | +$278K | ﹤0.01% | 5467 |
|
|
2024
Q2 | $188K | Sell |
6,600
-1,402
| -18% | -$49.2K | ﹤0.01% | 5713 |
|
|
2024
Q1 | $339K | Sell |
8,002
-2,956
| -27% | -$133K | ﹤0.01% | 5503 |
|
|
2023
Q4 | $586K | Buy |
10,958
+5,237
| +92% | +$236K | ﹤0.01% | 5228 |
|
|
2023
Q3 | $246K | Sell |
5,721
-33,559
| -85% | -$1.55M | ﹤0.01% | 5494 |
|
|
2023
Q2 | $2.16M | Buy |
39,280
+39,105
| +22,346% | +$2.15M | ﹤0.01% | 4381 |
|
|
2023
Q1 | $7.33K | Sell |
175
-174
| -50% | -$5.16K | ﹤0.01% | 6968 |
|
|
2022
Q4 | $9.66K | Sell |
349
-4,676
| -93% | -$115K | ﹤0.01% | 6954 |
|
|
2022
Q3 | $128K | Sell |
5,025
-2,698
| -35% | -$89.3K | ﹤0.01% | 5950 |
|
|
2022
Q2 | $277K | Buy |
7,723
+6,437
| +501% | +$291K | ﹤0.01% | 5727 |
|
|
2022
Q1 | $80K | Sell |
1,286
-570
| -31% | -$33.7K | ﹤0.01% | 6459 |
|
|
2021
Q4 | $131K | Buy |
1,856
+881
| +90% | +$62.6K | ﹤0.01% | 6285 |
|
|
2021
Q3 | $69K | Buy |
975
+129
| +15% | +$10.3K | ﹤0.01% | 6565 |
|
|
2021
Q2 | $71K | Buy |
846
+32
| +4% | +$2.26K | ﹤0.01% | 6504 |
|
|
2021
Q1 | $44K | Sell |
814
-2,476
| -75% | -$120K | ﹤0.01% | 6405 |
|
|
2020
Q4 | $142K | Buy |
3,290
+2,233
| +211% | +$83.3K | ﹤0.01% | 5765 |
|
|
2020
Q3 | $33K | Sell |
1,057
-811
| -43% | -$27.3K | ﹤0.01% | 5863 |
|
|
2020
Q2 | $58K | Buy |
1,868
+1,418
| +315% | +$38.2K | ﹤0.01% | 5627 |
|
|
2020
Q1 | $10K | Buy |
450
+400
| +800% | +$10.8K | ﹤0.01% | 6011 |
|
|
2019
Q4 | $2K | Sell |
50
-10
| -17% | -$288 | ﹤0.01% | 6499 |
|
|
2019
Q3 | $2K | Sell |
60
-6,781
| -99% | -$169K | ﹤0.01% | 6478 |
|
|
2019
Q2 | $137K | Buy |
6,841
+6,088
| +808% | +$178K | ﹤0.01% | 5182 |
|
|
2019
Q1 | $33K | Sell |
753
-7,840
| -91% | -$284K | ﹤0.01% | 5836 |
|
|
2018
Q4 | $273K | Sell |
8,593
-2,586
| -23% | -$102K | ﹤0.01% | 5148 |
|
|
2018
Q3 | $587K | Buy |
11,179
+2,515
| +29% | +$141K | ﹤0.01% | 4909 |
|
|
2018
Q2 | $463K | Buy |
8,664
+1,791
| +26% | +$91.7K | ﹤0.01% | 5161 |
|
|
2018
Q1 | $343K | Buy |
6,873
+3,897
| +131% | +$175K | ﹤0.01% | 5210 |
|
|
2017
Q4 | $99K | Buy |
2,976
+431
| +17% | +$14.6K | ﹤0.01% | 5635 |
|
|
2017
Q3 | $95K | Sell |
2,545
-873
| -26% | -$25.8K | ﹤0.01% | 5593 |
|
|
2017
Q2 | $88K | Buy |
3,418
+2,140
| +167% | +$52.9K | ﹤0.01% | 5681 |
|
|
2017
Q1 | $34K | Sell |
1,278
-4,256
| -77% | -$123K | ﹤0.01% | 5939 |
|
|
2016
Q4 | $169K | Buy |
5,534
+3,434
| +164% | +$87.3K | ﹤0.01% | 5406 |
|
|
2016
Q3 | $57K | Sell |
2,100
-1,028
| -33% | -$28.5K | ﹤0.01% | 5531 |
|
|
2016
Q2 | $90K | Buy |
3,128
+3,068
| +5,113% | +$97.6K | ﹤0.01% | 5284 |
|
|
2016
Q1 | $2K | Sell |
60
-70
| -54% | -$1.99K | ﹤0.01% | 6397 |
|
|
2015
Q4 | $4K | Buy |
130
+70
| +117% | +$2.39K | ﹤0.01% | 6411 |
|
|
2015
Q3 | $2K | Sell |
60
-973
| -94% | -$45.3K | ﹤0.01% | 6489 |
|
|
2015
Q2 | $59K | Sell |
1,033
-5,176
| -83% | -$295K | ﹤0.01% | 5796 |
|
|
2015
Q1 | $361K | Sell |
6,209
-4,253
| -41% | -$228K | ﹤0.01% | 4866 |
|
|
2014
Q4 | $594K | Sell |
10,462
-19,094
| -65% | -$910K | ﹤0.01% | 4542 |
|
|
2014
Q3 | $1.21M | Buy |
29,556
+5,664
| +24% | +$260K | ﹤0.01% | 3882 |
|
|
2014
Q2 | $1.09M | Buy |
23,892
+6,718
| +39% | +$282K | ﹤0.01% | 3988 |
|
|
2014
Q1 | $814K | Sell |
17,174
-2,840
| -14% | -$129K | ﹤0.01% | 4167 |
|
|
2013
Q4 | $941K | Sell |
20,014
-21,495
| -52% | -$939K | ﹤0.01% | 3978 |
|
|
2013
Q3 | $1.66M | Sell |
41,509
-9,883
| -19% | -$389K | ﹤0.01% | 3393 |
|
|
2013
Q2 | $1.83M | Buy |
+51,392
| New | +$1.97M | ﹤0.01% | 3220 |
|
Other funds holding HBIO
WCM
MIM
NCNMGF
CCM
Morgan Stanley's HBIO Position: Q2 2026 in Review
Morgan Stanley reduced its Harvard Bioscience (HBIO) stake by 0.06% in Q2 2026, selling an estimated $6 and leaving 1,627 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #7047.
Morgan Stanley first reported a position in HBIO in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.16M in Q2 2023. 37 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.
- Morgan Stanley held 1,627 shares of Harvard Bioscience worth $10K as of Q2 2026.
- Morgan Stanley sold 1 Harvard Bioscience share in Q2 2026, an estimated $6.
- Harvard Bioscience made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7047 holding.
- Morgan Stanley first reported a position in Harvard Bioscience in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Harvard Bioscience position peaked at $2.16M in Q2 2023.
- 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.